vimarsana.com

Latest Breaking News On - Ganesh raghu - Page 1 : vimarsana.com

Once-Promising Drug for Idiopathic Pulmonary Fibrosis Fails in Phase III Trial

Patients with IPF experience similar 48-week FVC declines with pamrevlumab, placebo

SAN DIEGO — The absolute change in FVC at 48 weeks was similar between patients with idiopathic pulmonary fibrosis receiving pamrevlumab vs. placebo, according to a presentation at the American Thoracic Society International Conference.Pamrevlumab (FibroGen) is a fully human monoclonal antibody that impedes connective tissue growth factor, according to researchers.

Pamrevlumab Treatment for Idiopathic Pulmonary Fibrosis

Pamrevlumab Treatment for Idiopathic Pulmonary Fibrosis
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.